1. Home
  2. EVAX vs AIMD Comparison

EVAX vs AIMD Comparison

Compare EVAX & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • AIMD
  • Stock Information
  • Founded
  • EVAX 2008
  • AIMD 1984
  • Country
  • EVAX Denmark
  • AIMD United States
  • Employees
  • EVAX N/A
  • AIMD N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVAX Health Care
  • AIMD Health Care
  • Exchange
  • EVAX Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • EVAX 15.1M
  • AIMD 11.9M
  • IPO Year
  • EVAX 2021
  • AIMD N/A
  • Fundamental
  • Price
  • EVAX $2.64
  • AIMD $2.94
  • Analyst Decision
  • EVAX Strong Buy
  • AIMD
  • Analyst Count
  • EVAX 2
  • AIMD 0
  • Target Price
  • EVAX $10.00
  • AIMD N/A
  • AVG Volume (30 Days)
  • EVAX 101.0K
  • AIMD 72.7K
  • Earning Date
  • EVAX 08-13-2025
  • AIMD 08-04-2025
  • Dividend Yield
  • EVAX N/A
  • AIMD N/A
  • EPS Growth
  • EVAX N/A
  • AIMD N/A
  • EPS
  • EVAX N/A
  • AIMD N/A
  • Revenue
  • EVAX $3,293,000.00
  • AIMD $106,207.00
  • Revenue This Year
  • EVAX N/A
  • AIMD N/A
  • Revenue Next Year
  • EVAX N/A
  • AIMD N/A
  • P/E Ratio
  • EVAX N/A
  • AIMD N/A
  • Revenue Growth
  • EVAX 2555.64
  • AIMD 13.38
  • 52 Week Low
  • EVAX $1.20
  • AIMD $2.00
  • 52 Week High
  • EVAX $17.75
  • AIMD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 55.56
  • AIMD 50.61
  • Support Level
  • EVAX $2.26
  • AIMD $3.07
  • Resistance Level
  • EVAX $2.60
  • AIMD $3.34
  • Average True Range (ATR)
  • EVAX 0.21
  • AIMD 0.24
  • MACD
  • EVAX -0.02
  • AIMD 0.04
  • Stochastic Oscillator
  • EVAX 51.32
  • AIMD 60.37

About EVAX Evaxion Biotech

Evaxion AS is in the field of oncology. It used the AI-Immunology platform.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: